Your browser doesn't support javascript.
loading
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature.
Teruel, María; Barturen, Guillermo; Martínez-Bueno, Manuel; Castellini-Pérez, Olivia; Barroso-Gil, Miguel; Povedano, Elena; Kerick, Martin; Català-Moll, Francesc; Makowska, Zuzanna; Buttgereit, Anne; Pers, Jacques-Olivier; Marañón, Concepción; Ballestar, Esteban; Martin, Javier; Carnero-Montoro, Elena; Alarcón-Riquelme, Marta E.
Afiliación
  • Teruel M; GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
  • Barturen G; GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
  • Martínez-Bueno M; GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
  • Castellini-Pérez O; GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
  • Barroso-Gil M; GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
  • Povedano E; GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
  • Kerick M; IPBLN-CSIC, Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, 18016, Granada, Spain.
  • Català-Moll F; Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain.
  • Makowska Z; IDIBELL, Bellvitge Biomedical Research Institute 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Buttgereit A; Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany.
  • Marañón C; Université de Brest, INSERM, Labex IGO, CHU de Brest, Brest, France.
  • Ballestar E; GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.
  • Martin J; Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain.
  • Carnero-Montoro E; IDIBELL, Bellvitge Biomedical Research Institute 08907 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Alarcón-Riquelme ME; IPBLN-CSIC, Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, 18016, Granada, Spain.
Sci Rep ; 11(1): 23292, 2021 12 02.
Article en En | MEDLINE | ID: mdl-34857786
Primary Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics study, we confirmed a vast coordinated hypomethylation and overexpression effects in IFN-related genes, what is known as the IFN signature. Stratified and conditional analyses suggest a strong interaction between SS-associated HLA genetic variation and the presence of Anti-Ro/SSA autoantibodies in driving the IFN epigenetic signature and determining SS. We report a novel epigenetic signature characterized by increased DNA methylation levels in a large number of genes enriched in pathways such as collagen metabolism and extracellular matrix organization. We identified potential new genetic variants associated with SS that might mediate their risk by altering DNA methylation or gene expression patterns, as well as disease-interacting genetic variants that exhibit regulatory function only in the SS population. Our study sheds new light on the interaction between genetics, autoantibody profiles, DNA methylation and gene expression in SS, and contributes to elucidate the genetic architecture of gene regulation in an autoimmune population.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Autoanticuerpos / Variación Genética / Síndrome de Sjögren / Expresión Génica / Regulación de la Expresión Génica / Interferones / Epigenómica / Antígenos HLA Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Autoanticuerpos / Variación Genética / Síndrome de Sjögren / Expresión Génica / Regulación de la Expresión Génica / Interferones / Epigenómica / Antígenos HLA Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2021 Tipo del documento: Article País de afiliación: España